Home
New Patients
Current Patients
AOH Staff
Cancer Information
Clinical Research
Staff Only
 

 


PATIENT PORTAL

 

 

CLINICAL RESEARCH

AOH is dedicated to compassionate and state of the art quality patient care.  Access to innovative treatments through clinical trials is an important component of modern oncology care, but for many years was only really available at tertiary or university centers.  We are proud to have a research program at AOH that offers patients the opportunity to receive cutting edge treatments in their own community that may not otherwise be available to them.  Currently, our research department offers clinical trials via several pathways:


Mikhail Kalnitsky
Certified Clinical Research Coordinator

 

THE CLINICAL TRIALS SUPPORT UNIT (CTSU)

Overseen by the National Cancer Institute, the CTSU is a program that allows community practices access to large Phase III clinical trials usually developed by national oncology research cooperative groups.  These trials attempt to answer pivotal questions in the field of oncology and have led to advances in the standard of care treatment for many of the most common cancers, such as breast, lung, and colon cancer.

PHARMACEUTICAL COMPANY SPONSORED CLINICAL TRIALS

This allows our patients access to some of the most innovative and promising treatments through clinical trials that may not be available through the other pathways. Several of these trials in which AOH has enrolled patients have led to the FDA approval of new and effective treatments for lymphoma and colon cancer.

Participation in a clinical trial may not be appropriate for everyone.  For more information on AOH clinical trials, please speak with your AOH physician, or our research coordinator, Mikhail Kalnitsky.  For additional information on NCI clinical trials, you may also contact our NIH liaison research coordinator, Christine Muir.

 

Associates in Oncology & Hematology © 2008 All Rights Reserverd